Solutions for Collaborative Networked Pharma Research
In a shift from the long established business model, life sciences research is now often carried out in collaborative networks that include pharma companies, biotechs, CROs, academia and research institutes working together on a single research project and jointly developing intellectual property.
An estimated 30-50% of all spending on discovery projects is now spent outside the sponsoring organisation and up to 60% of all innovation in top pharma companies may be derived from external sources.
At the same time many of these joint discovery projects are failing for a variety of reasons, including poor communication and data/reporting inconsistencies.
Read this Whitepaper from Dotmatics to explore ways to optimize collaborative networked pharma research and access a case study from one of pharma's top companies.
Download your copy today
|Benefits of Reading this Whitepaper||Challenges Addressed|